health1 hour ago
FDA Class II Recall Targets 3,744 Bottles of Generic Blood Pressure Meds for Dissolution Failures
Macleods Pharmaceuticals initiated a nationwide recall of over 3,700 bottles of generic blood pressure tablets on October 7, 2026, due to failed dissolution specifications. The FDA classified this as a Class II recall on October 26, indicating potential temporary adverse effects but unlikely serious harm. Affected lots contain Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide. Patients are advised to check lot numbers and consult their doctors before stopping treatment, as brand-name versions are not affected.
